Nonsurgical Management of Oligozoospermia

  • General Department of Preventive Medicine ROR
  • University of Washington ROR

The Journal of Clinical Endocrinology and Metabolism, 105(12), e4194-e4207

DOI 10.1210/clinem/dgaa390 PMID 32583849

Abstract

Male infertility secondary to oligozoospermia is surprisingly common. Although a majority of cases are idiopathic, oligozoospermia can be caused by endocrine dysfunction, anatomic abnormalities, medications, or environmental exposures. The work-up includes excluding reversible factors such as hormonal deficiency, medication effects, and retrograde ejaculation and identifying any underlying genetic syndrome and treating reversible medical causes. If no reversible cause is found, appropriate referrals to urology and assisted reproductive technology should be initiated. Lastly, clinicians should be aware of and respond to the psychological and general health ramifications of a diagnosis of oligozoospermia as part of the comprehensive care of men and couples struggling with a diagnosis of infertility.

Topics

oligozoospermia treatment, male infertility management, nonsurgical male factor, low sperm count, hormonal male infertility, clomiphene citrate men, aromatase inhibitor male, idiopathic oligozoospermia, spermatogenesis optimization, male reproductive endocrinology
PMID 32583849 32583849 DOI 10.1210/clinem/dgaa390 10.1210/clinem/dgaa390

Cite this article

Choy, J. T., & Amory, J. K. (2020). Nonsurgical Management of Oligozoospermia. *The Journal of clinical endocrinology and metabolism*, *105*(12), e4194-e4207. https://doi.org/10.1210/clinem/dgaa390

Related articles